Cargando…
Short-term cost-effectiveness analysis of tirzepatide for the treatment of type 2 diabetes in the United States
BACKGROUND: Tirzepatide is a novel once-a-week dual glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 receptor agonist that is used as an addition to diet and exercise to improve blood glucose in adults with type 2 diabetes. It is the first dual glucagon-like peptide-1 and glu...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Academy of Managed Care Pharmacy
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10388019/ https://www.ncbi.nlm.nih.gov/pubmed/36840958 http://dx.doi.org/10.18553/jmcp.2023.29.3.276 |